Osteoporosis and vertebral compression fractures latest treatment

Dr Joshua Hirsch from Massachusetts General Hospital and Liz Thompson, CEO of the National Osteoporosis Foundation, discuss back injuries resulting from a number of conditions such as osteoporosis and vertebral compression fractures (VCF) and the latest technology to provide the most up-to-date treatment.

Dr. Joshua Hirsch from Massachusetts General Hospital MD FACR FSIR FSNIS is director of Interventional Neuroradiology, chief of the Interventional Spine Service, vice chair of Interventional Radiology Quality & Safety and associate Departmental Quality Chair.  He has extensive experience in diagnosis, management and treatment of cerebrovascular disease, minimally invasive spine surgery and acute stroke treatment.Dr. Hirsch has published over 450 papers, 40 chapters and edited multiple books in the peer-reviewed literature. He is a founding editor of the Journal of NeuroInterventional Surgery and is a past president of both the American Society of Spine Radiology (ASSR) and the Society of NeuroInterventional Surgery (SNIS). He has been elected to the board of the American Society of Interventional Pain Physicians (ASIPP), the Society for Injectable Osteoarticular Biomaterials and the American Society of Neuroradiology (ASNR). He is chair of a committee for academicians at the American College of Radiology. Dr. Hirsch was named a senior affiliate research fellow of the Neiman Policy Institute. He is an advisor to the RUC, chairs the health policy committee and member of the Niekro Foundation’s Medical Advisory Board. Dr. Hirsch co-chairs the Neuro-Psychiatric working group developing episodic cost measures.Dr. Hirsch has received numerous awards including ones for transformational leadership at the ASSR, distinguished service at the ASNR and academic achievement at ASIPP. He has been named one of America’s Top Doctors and a Best of Boston physician for multiple consecutive years. He is a member of the Marquis Who’s Who and was recently awarded the 100 designation from the MGH’s Cancer Center. He has been named an inaugural fellow of the SNIS for his many contributions to the field of NeuroInterventional Surgery.